SEMAGLUTIDE Pharmacologic Class Indexing
- Class set ID
- 5a311475-e1bf-47f7-9ac3-68c308ce5c4c
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 | Novo Nordisk Pharmaceutical Industries, LP | 20260519 | 19 |
| These highlights do not include all the information needed to use WEGOVY ® safely and effectively. See full prescribing information for WEGOVY. WEGOVY (semaglutide) injection, for subcutaneous use WEGOVY (semaglutide) tablets, for oral use Initial U.S. Approval: 2017 | Novo Nordisk Pharmaceutical Industries, LP | 20260505 | 18 |
| These highlights do not include all the information needed to use RYBELSUS ® and OZEMPIC ® tablets safely and effectively. See full prescribing information for RYBELSUS and OZEMPIC tablets. RYBELSUS (semaglutide) tablets, for oral use OZEMPIC (semaglutide) tablets, for oral use Initial U.S. Approval: 2017 | Novo Nordisk Pharmaceutical Industries, LP | 20260130 | 13 |
| These highlights do not include all the information needed to use WEGOVY safely and effectively. See full prescribing information for WEGOVY. WEGOVY (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 | A-S Medication Solutions | 20240423 | 6 |
| These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 | A-S Medication Solutions | 20231122 | 3 |
| These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 | A-S Medication Solutions | 20231117 | 6 |
| These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 | A-S Medication Solutions | 20210114 | 1 |
| These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 | A-S Medication Solutions | 20200917 | 1 |